Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

A federal judge’s ruling restricts compounding pharmacies from producing generic Zepbound, sparking concerns over ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest ...